Pages that link to "Q33680928"
Jump to navigation
Jump to search
The following pages link to Synergism of CPT-11 and Apo2L/TRAIL against two differentially sensitive human colon tumor xenografts (Q33680928):
Displaying 4 items.
- Influence of the implantation site on the sensitivity of patient pancreatic tumor xenografts to Apo2L/TRAIL therapy (Q35063836) (← links)
- Tumor priming by Apo2L/TRAIL reduces interstitial fluid pressure and enhances efficacy of liposomal gemcitabine in a patient derived xenograft tumor model (Q36218165) (← links)
- Immune cell-mediated liver injury (Q37521988) (← links)
- Low-dose 5-fluorouracil sensitizes HepG2 cells to TRAIL through TRAIL receptor DR5 and survivin-dependent mechanisms (Q51206705) (← links)